Company news

Hofseth Biocare Asa (OSL:HBC) news

Hofseth Biocare Asa news releases on 6ix. Latest, Sep 17, 2026: Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION

View Hofseth Biocare Asa →

Press releases & updates

Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION

September 17, 2026

HOFSETH BIOCARE ASA: MANAGEMENT CHANGE

September 1, 2026

Hofseth BioCare ASA: SECOND QUARTER 2026 FINANCIAL REPORT

August 21, 2026

Hofseth Biocare ASA: Notification of major shareholdings

July 31, 2026

HOFSETH BIOCARE ASA: EXTRAORDINARY GENERAL MEETING COMPLETED

July 30, 2026

Hofseth BioCare ASA: NEW PEER-REVIEWED CLINICAL STUDY ON PROGO® PUBLISHED IN BIOMEDICINES DEMONSTRATES GLP-1 BENEFITS AND AN INCREASE LEAN MUSCLE MASS

July 27, 2026

HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

July 9, 2026

HOFSETH BIOCARE ASA: MAJOR SHAREHOLDER NOTIFICATION

July 7, 2026

HOFSETH BIOCARE ASA: NEW SHARE CAPITAL REGISTERED

July 3, 2026

HOFSETH BIOCARE ASA: ANNUAL GENERAL MEETING COMPLETED

June 30, 2026

HOFSETH BIOCARE ASA: MANDATORY NOTIFICATION OF TRADE

June 29, 2026

HOFSETH BIOCARE ASA: DISCLOSURES OF LARGE SHAREHOLDINGS

June 29, 2026

HOFSETH BIOCARE ASA – VOTING UNDERTAKINGS SECURED IN RELATION TO PRIVATE PLACEMENT AND B-SHARE AMENDMENTS

June 29, 2026

HOFSETH BIOCARE ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED

June 28, 2026

HOFSETH BIOCARE ASA: CONTEMPLATED PRIVATE PLACEMENT

June 26, 2026

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026

June 9, 2026

Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M

May 21, 2026

Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas

April 14, 2026

Hofseth BioCare ASA: HBC ANNUAL REPORT 2025

March 27, 2026

Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT

February 13, 2026

Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement

December 15, 2025

Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING

November 21, 2025

Hofseth BioCare ASA: Extraordinary General Meeting completed

November 20, 2025

Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING

November 20, 2025

Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE

November 20, 2025

Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering

November 10, 2025

Hofseth BioCare ASA: Terms of the Subsequent Offering

November 7, 2025

Hofseth BioCare ASA: THIRD QUARTER 2025 FINANCIAL REPORT

November 7, 2025

Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

October 30, 2025

Ex. Subsequent Offering Today

October 27, 2025

Hofseth BioCare ASA: Key Information Relating to Subsequent Offering

October 27, 2025

Hofseth BioCare ASA: Disclosures of Large Shareholdings

October 27, 2025

Hofseth BioCare ASA: Private placement successfully placed

October 27, 2025

Hofseth Biocare ASA: USD 5 Million Divestment in Aecorbio

October 24, 2025

Hofseth BioCare ASA: Contemplated Private Placement and Partial Divestment of Shares in Aecorbio

October 24, 2025

Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER

September 17, 2025

Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways

September 9, 2025

Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn

September 4, 2025

Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT

August 22, 2025

Hofseth Biocare ASA: HBC’s ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago

July 16, 2025

Hofseth Biocare ASA: Annual General Meeting completed

May 23, 2025

Hofseth Biocare ASA: FIRST QUARTER 2025 FINANCIAL REPORT

May 16, 2025

Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US

May 5, 2025

Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS

May 5, 2025

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2025

May 2, 2025